BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31065973)

  • 1. Toll-Like Receptor 4 Promotes Th17 Lymphocyte Infiltration Via CCL25/CCR9 in Pathogenesis of Experimental Autoimmune Encephalomyelitis.
    Zhang Y; Han J; Wu M; Xu L; Wang Y; Yuan W; Hua F; Fan H; Dong F; Qu X; Yao R
    J Neuroimmune Pharmacol; 2019 Sep; 14(3):493-502. PubMed ID: 31065973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
    Samus M; Li YT; Sorokin L; Rottner K; Vestweber D
    J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-β regulates Th17 differentiation partly through the inhibition of osteopontin in experimental autoimmune encephalomyelitis.
    Zhao Q; Cheng W; Xi Y; Cao Z; Xu Y; Wu T; Li C; Niu X; Chen G
    Mol Immunol; 2018 Jan; 93():20-30. PubMed ID: 29127843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiamine deficiency promotes T cell infiltration in experimental autoimmune encephalomyelitis: the involvement of CCL2.
    Ji Z; Fan Z; Zhang Y; Yu R; Yang H; Zhou C; Luo J; Ke ZJ
    J Immunol; 2014 Sep; 193(5):2157-67. PubMed ID: 25063874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aurintricarboxylic acid ameliorates experimental autoimmune encephalomyelitis by blocking chemokine-mediated pathogenic cell migration and infiltration.
    Zhang F; Wei W; Chai H; Xie X
    J Immunol; 2013 Feb; 190(3):1017-25. PubMed ID: 23267022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR4-RelA-miR-30a signal pathway regulates Th17 differentiation during experimental autoimmune encephalomyelitis development.
    Qu X; Han J; Zhang Y; Wang X; Fan H; Hua F; Yao R
    J Neuroinflammation; 2019 Sep; 16(1):183. PubMed ID: 31561751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
    Chung CY; Liao F
    J Neuroinflammation; 2016 Apr; 13(1):76. PubMed ID: 27068264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LFA-1 Controls Th1 and Th17 Motility Behavior in the Inflamed Central Nervous System.
    Dusi S; Angiari S; Pietronigro EC; Lopez N; Angelini G; Zenaro E; Della Bianca V; Tosadori G; Paris F; Amoruso A; Carlucci T; Constantin G; Rossi B
    Front Immunol; 2019; 10():2436. PubMed ID: 31681316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cells promote induction of experimental autoimmune encephalomyelitis by facilitating reactivation of T cells in the central nervous system.
    Pierson ER; Stromnes IM; Goverman JM
    J Immunol; 2014 Feb; 192(3):929-39. PubMed ID: 24367024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daphnetin Alleviates Experimental Autoimmune Encephalomyelitis via Regulating Dendritic Cell Activity.
    Wang D; Lu Z; Zhang H; Jin SF; Yang H; Li YM; Shi LY
    CNS Neurosci Ther; 2016 Jul; 22(7):558-67. PubMed ID: 27013083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
    Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
    J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-21R signaling is critical for induction of spontaneous experimental autoimmune encephalomyelitis.
    Lee Y; Mitsdoerffer M; Xiao S; Gu G; Sobel RA; Kuchroo VK
    J Clin Invest; 2015 Nov; 125(11):4011-20. PubMed ID: 26413871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of tumour necrosis factor-α in experimental autoimmune encephalomyelitis reveals differential effects on the antigen-specific immune response and central nervous system histopathology.
    Batoulis H; Recks MS; Holland FO; Thomalla F; Williams RO; Kuerten S
    Clin Exp Immunol; 2014 Jan; 175(1):41-8. PubMed ID: 24111507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis.
    Marta M; Andersson A; Isaksson M; Kämpe O; Lobell A
    Eur J Immunol; 2008 Feb; 38(2):565-75. PubMed ID: 18203139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of beta7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn's disease.
    Apostolaki M; Manoloukos M; Roulis M; Wurbel MA; Müller W; Papadakis KA; Kontoyiannis DL; Malissen B; Kollias G
    Gastroenterology; 2008 Jun; 134(7):2025-35. PubMed ID: 18439426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginsenoside-Re inhibits experimental autoimmune encephalomyelitis as a mouse model of multiple sclerosis by downregulating TLR4/MyD88/NF-κB signaling pathways.
    Oh J; Kwon TW; Choi JH; Kim Y; Moon SK; Nah SY; Cho IH
    Phytomedicine; 2024 Jan; 122():155065. PubMed ID: 37856989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-1 overexpression exacerbate experimental allergic encephalomyelitis.
    Guo Y; Chung SK; Siu CW; Kwan SC; Ho PW; Yeung PK; Chan KH
    J Neuroimmunol; 2014 Nov; 276(1-2):64-70. PubMed ID: 25205217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinin B2 receptor regulates chemokines CCL2 and CCL5 expression and modulates leukocyte recruitment and pathology in experimental autoimmune encephalomyelitis (EAE) in mice.
    Dos Santos AC; Roffê E; Arantes RM; Juliano L; Pesquero JL; Pesquero JB; Bader M; Teixeira MM; Carvalho-Tavares J
    J Neuroinflammation; 2008 Nov; 5():49. PubMed ID: 18986535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitonin gene-related peptide enhances experimental autoimmune encephalomyelitis by promoting Th17-cell functions.
    Mikami N; Watanabe K; Hashimoto N; Miyagi Y; Sueda K; Fukada S; Yamamoto H; Tsujikawa K
    Int Immunol; 2012 Nov; 24(11):681-91. PubMed ID: 22843730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon regulatory factor (IRF) 3 is critical for the development of experimental autoimmune encephalomyelitis.
    Fitzgerald DC; O'Brien K; Young A; Fonseca-Kelly Z; Rostami A; Gran B
    J Neuroinflammation; 2014 Jul; 11():130. PubMed ID: 25069698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.